RemeGen’s Disitamab Vedotin Shows Positive Trial Results
PremiumCompany AnnouncementsRemeGen’s Disitamab Vedotin Shows Positive Trial Results
1M ago
RemeGen Co. to Discuss Share Issuance Plan
PremiumCompany Announcements
RemeGen Co. to Discuss Share Issuance Plan
2M ago
RemeGen Co. Ltd. Schedules 2023 Annual Meeting
PremiumCompany Announcements
RemeGen Co. Ltd. Schedules 2023 Annual Meeting
2M ago
RemeGen Sets Shareholder Record Date for EGM Voting
PremiumCompany AnnouncementsRemeGen Sets Shareholder Record Date for EGM Voting
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100